Apligraf: Difference between revisions
Jump to navigation
Jump to search
m decapitalize category names |
m remove <coauthors> parameter |
||
| Line 23: | Line 23: | ||
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | ||
| last= | |last= | ||
| first | |first= | ||
|url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | |||
| url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | ||
| title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | |date=November 2011 | ||
| date=November 2011 | |publisher=FDA | ||
| publisher=FDA | |quote= | ||
| quote= | |accessdate=2011-12-20 | ||
| accessdate=2011-12-20 | |||
}}</ref> | }}</ref> | ||
Revision as of 20:33, 19 October 2019
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(error)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
